tru4-1

Nucleoside analogues work by blocking the replication of SARS-CoV-2 genome.

Management of asymptomatic SARS-Co-V infection is based on:

There are multiple pathogenetic targets for treatment of SARS-CoV-2 infection.

What are the advantages associated with the use of nanomaterials in the diagnosis and treatment of SARS-CoV-2 infection?

The size of SARS-CoV-2 viral particles is within the nanoscale range.